These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8051955)

  • 1. Effect of ageing on erythrocyte aldose reductase and sorbitol dehydrogenase activity.
    Funasako M; Fujimoto K; Taniji M; Suruda T; Nakai S; Kobayashi H; Sakagami Y; Ohata M
    Mech Ageing Dev; 1994 Feb; 73(2):137-43. PubMed ID: 8051955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crucial role of aldose reductase activity and plasma glucose level in sorbitol accumulation in erythrocytes from diabetic patients.
    Hamada Y; Kitoh R; Raskin P
    Diabetes; 1991 Oct; 40(10):1233-40. PubMed ID: 1936586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of aldose reductase in human erythrocytes by vitamin C.
    Vincent TE; Mendiratta S; May JM
    Diabetes Res Clin Pract; 1999 Jan; 43(1):1-8. PubMed ID: 10199583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophil aldose reductase activity and its association with established diabetic microvascular complications.
    Dent MT; Tebbs SE; Gonzalez AM; Ward JD; Wilson RM
    Diabet Med; 1991 Jun; 8(5):439-42. PubMed ID: 1830528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency.
    Ii S; Ohta M; Kudo E; Yamaoka T; Tachikawa T; Moritani M; Itakura M; Yoshimoto K
    Diabetologia; 2004 Mar; 47(3):541-548. PubMed ID: 14968292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased erythrocyte aldose reductase activity in type 1 diabetic patients.
    Hamada Y; Kito R; Raskin P
    Diabet Med; 1991 Apr; 8(3):226-31. PubMed ID: 1828737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of interindividual variability of aldose reductase protein content on polyol-pathway metabolites and redox state in erythrocytes in diabetic patients.
    Hamada Y; Nishimura C; Koh N; Sakakibara F; Nakamura J; Tanimoto T; Hotta N
    Diabetes Care; 1998 Jun; 21(6):1014-8. PubMed ID: 9614624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microdetermination of aldose and aldehyde reductases from human tissues.
    Song HP; Das B; Srivastava SK
    Curr Eye Res; 1987 Aug; 6(8):1001-6. PubMed ID: 3117493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of aldose reductase, sorbitol dehydrogenase, and taurine cotransporter mRNA in rat medulla.
    Martial S; Price SR; Sands JM
    J Am Soc Nephrol; 1995 May; 5(11):1971-8. PubMed ID: 7620095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperglycemia-induced activation of human erythrocyte aldose reductase and alterations in kinetic properties.
    Srivastava SK; Ansari NH; Hair GA; Jaspan J; Rao MB; Das B
    Biochim Biophys Acta; 1986 Mar; 870(2):302-11. PubMed ID: 3082363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is sorbitol dehydrogenase gene expression affected by streptozotocin-diabetes in the rat?
    Kicic E; Palmer TN
    Biochim Biophys Acta; 1994 May; 1226(2):213-8. PubMed ID: 8204669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythrocyte sorbitol, sorbitol dehydrogenase (SDH) and glyceraldehyde reductase (GAR) in diabetes mellitus].
    Hosojima H
    Nihon Rinsho; 1998 Jan; 56 Suppl 3():175-80. PubMed ID: 9513410
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of the effects of inhibitors of aldose reductase and sorbitol dehydrogenase on neurovascular function, nerve conduction and tissue polyol pathway metabolites in streptozotocin-diabetic rats.
    Cameron NE; Cotter MA; Basso M; Hohman TC
    Diabetologia; 1997 Mar; 40(3):271-81. PubMed ID: 9084964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased white cell aldose reductase mRNA levels in diabetic patients.
    Kicic E; Palmer TN
    Diabetes Res Clin Pract; 1996 Jun; 33(1):31-6. PubMed ID: 8877273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of erythrocyte aldose reductase in man in response to glycaemic challenge.
    Lyons PA; Gould S; Wise PH; Palmer TN
    Diabetes Res Clin Pract; 1991 Oct; 14(1):9-13. PubMed ID: 1748066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldose reductase and sorbitol dehydrogenase distribution in substructures of normal and diabetic rat lens.
    Collins JG; Corder CN
    Invest Ophthalmol Vis Sci; 1977 Mar; 16(3):242-3. PubMed ID: 403152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coordinated response of renal medullary enzymes regulating net sorbitol production in diuresis and antidiuresis.
    Sands JM; Schrader DC
    J Am Soc Nephrol; 1990 Jul; 1(1):58-65. PubMed ID: 2129508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase and sorbitol dehydrogenase activities in diabetic brain: in vivo kinetic studies using 19F 3-FDG NMR in rats.
    Kwee IL; Igarashi H; Nakada T
    Neuroreport; 1996 Feb; 7(3):726-8. PubMed ID: 8733731
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osmoregulation by slow changes in aldose reductase and rapid changes in sorbitol flux.
    Bagnasco SM; Murphy HR; Bedford JJ; Burg MB
    Am J Physiol; 1988 Jun; 254(6 Pt 1):C788-92. PubMed ID: 3132044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrocytic sorbitol contents in diabetic patients correlate with blood aldose reductase protein contents and plasma glucose levels, and are normalized by the potent aldose reductase inhibitor fidarestat (SNK-860).
    Asano T; Saito Y; Kawakami M; Yamada N; Sekino H; Hasegawa S;
    J Diabetes Complications; 2004; 18(6):336-42. PubMed ID: 15531183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.